Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India

BACKGROUND: This post hoc analysis evaluated the efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) from India. METHODS: Changes from baseline in HbA(1c), fasting plasma glucose (FPG), body weight, and blood pressure (B...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Endocrinol Metab
Main Authors: Prasanna Kumar, K. M., Mohan, Viswanathan, Sethi, Bipin, Gandhi, Pramod, Bantwal, Ganapathi, Xie, John, Meininger, Gary, Qiu, Rong
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4855968/
https://ncbi.nlm.nih.gov/pubmed/27186557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.179996
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados